Trifolirhizin can improve psoriasis-like keratinocyte hyperproliferation and excessive synthesis and secretion of inflammatory cytokines IL-8 and IL-12, thereby alleviating psoriasis lesions, probably dependent on reversal of impaired autophagy induced by AMPK-mTOR signaling pathway inhibition. Here, CXCL8 is linked to psoriasis.